Medical Care
Global Liposome Assisted Drug Delivery Market Research Report 2025
- Sep 18, 25
- ID: 508815
- Pages: 83
- Figures: 90
- Views: 19
This report aims to provide a comprehensive presentation of the global market for Liposome Assisted Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposome Assisted Drug Delivery.
The Liposome Assisted Drug Delivery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liposome Assisted Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposome Assisted Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau Group
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Segment by Type
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Segment by Application
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liposome Assisted Drug Delivery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Liposome Assisted Drug Delivery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liposome Assisted Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposome Assisted Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau Group
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Segment by Type
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Segment by Application
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liposome Assisted Drug Delivery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liposome Assisted Drug Delivery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposome Assisted Drug Delivery Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liposome Assisted Drug Delivery Market Perspective (2020-2031)
2.2 Global Liposome Assisted Drug Delivery Growth Trends by Region
2.2.1 Global Liposome Assisted Drug Delivery Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Liposome Assisted Drug Delivery Historic Market Size by Region (2020-2025)
2.2.3 Liposome Assisted Drug Delivery Forecasted Market Size by Region (2026-2031)
2.3 Liposome Assisted Drug Delivery Market Dynamics
2.3.1 Liposome Assisted Drug Delivery Industry Trends
2.3.2 Liposome Assisted Drug Delivery Market Drivers
2.3.3 Liposome Assisted Drug Delivery Market Challenges
2.3.4 Liposome Assisted Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liposome Assisted Drug Delivery Players by Revenue
3.1.1 Global Top Liposome Assisted Drug Delivery Players by Revenue (2020-2025)
3.1.2 Global Liposome Assisted Drug Delivery Revenue Market Share by Players (2020-2025)
3.2 Global Liposome Assisted Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Liposome Assisted Drug Delivery Revenue
3.4 Global Liposome Assisted Drug Delivery Market Concentration Ratio
3.4.1 Global Liposome Assisted Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liposome Assisted Drug Delivery Revenue in 2024
3.5 Global Key Players of Liposome Assisted Drug Delivery Head office and Area Served
3.6 Global Key Players of Liposome Assisted Drug Delivery, Product and Application
3.7 Global Key Players of Liposome Assisted Drug Delivery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Liposome Assisted Drug Delivery Breakdown Data by Type
4.1 Global Liposome Assisted Drug Delivery Historic Market Size by Type (2020-2025)
4.2 Global Liposome Assisted Drug Delivery Forecasted Market Size by Type (2026-2031)
5 Liposome Assisted Drug Delivery Breakdown Data by Application
5.1 Global Liposome Assisted Drug Delivery Historic Market Size by Application (2020-2025)
5.2 Global Liposome Assisted Drug Delivery Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Liposome Assisted Drug Delivery Market Size (2020-2031)
6.2 North America Liposome Assisted Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Liposome Assisted Drug Delivery Market Size by Country (2020-2025)
6.4 North America Liposome Assisted Drug Delivery Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liposome Assisted Drug Delivery Market Size (2020-2031)
7.2 Europe Liposome Assisted Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Liposome Assisted Drug Delivery Market Size by Country (2020-2025)
7.4 Europe Liposome Assisted Drug Delivery Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liposome Assisted Drug Delivery Market Size (2020-2031)
8.2 Asia-Pacific Liposome Assisted Drug Delivery Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Liposome Assisted Drug Delivery Market Size by Region (2020-2025)
8.4 Asia-Pacific Liposome Assisted Drug Delivery Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liposome Assisted Drug Delivery Market Size (2020-2031)
9.2 Latin America Liposome Assisted Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Liposome Assisted Drug Delivery Market Size by Country (2020-2025)
9.4 Latin America Liposome Assisted Drug Delivery Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liposome Assisted Drug Delivery Market Size (2020-2031)
10.2 Middle East & Africa Liposome Assisted Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Liposome Assisted Drug Delivery Market Size by Country (2020-2025)
10.4 Middle East & Africa Liposome Assisted Drug Delivery Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Details
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Liposome Assisted Drug Delivery Introduction
11.1.4 Gilead Sciences Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.1.5 Gilead Sciences Recent Development
11.2 Pacira
11.2.1 Pacira Company Details
11.2.2 Pacira Business Overview
11.2.3 Pacira Liposome Assisted Drug Delivery Introduction
11.2.4 Pacira Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.2.5 Pacira Recent Development
11.3 Sun Pharmaceutical
11.3.1 Sun Pharmaceutical Company Details
11.3.2 Sun Pharmaceutical Business Overview
11.3.3 Sun Pharmaceutical Liposome Assisted Drug Delivery Introduction
11.3.4 Sun Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.3.5 Sun Pharmaceutical Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Liposome Assisted Drug Delivery Introduction
11.4.4 Johnson & Johnson Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.4.5 Johnson & Johnson Recent Development
11.5 Luye Pharma
11.5.1 Luye Pharma Company Details
11.5.2 Luye Pharma Business Overview
11.5.3 Luye Pharma Liposome Assisted Drug Delivery Introduction
11.5.4 Luye Pharma Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.5.5 Luye Pharma Recent Development
11.6 Sigma-Tau Group
11.6.1 Sigma-Tau Group Company Details
11.6.2 Sigma-Tau Group Business Overview
11.6.3 Sigma-Tau Group Liposome Assisted Drug Delivery Introduction
11.6.4 Sigma-Tau Group Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.6.5 Sigma-Tau Group Recent Development
11.7 Ipsen (Onivyde)
11.7.1 Ipsen (Onivyde) Company Details
11.7.2 Ipsen (Onivyde) Business Overview
11.7.3 Ipsen (Onivyde) Liposome Assisted Drug Delivery Introduction
11.7.4 Ipsen (Onivyde) Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.7.5 Ipsen (Onivyde) Recent Development
11.8 CSPC
11.8.1 CSPC Company Details
11.8.2 CSPC Business Overview
11.8.3 CSPC Liposome Assisted Drug Delivery Introduction
11.8.4 CSPC Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.8.5 CSPC Recent Development
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Details
11.9.2 Teva Pharmaceutical Business Overview
11.9.3 Teva Pharmaceutical Liposome Assisted Drug Delivery Introduction
11.9.4 Teva Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.9.5 Teva Pharmaceutical Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Liposome Assisted Drug Delivery Introduction
11.10.4 Novartis Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.10.5 Novartis Recent Development
11.11 Fudan-Zhangjiang
11.11.1 Fudan-Zhangjiang Company Details
11.11.2 Fudan-Zhangjiang Business Overview
11.11.3 Fudan-Zhangjiang Liposome Assisted Drug Delivery Introduction
11.11.4 Fudan-Zhangjiang Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.11.5 Fudan-Zhangjiang Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liposome Assisted Drug Delivery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposome Assisted Drug Delivery Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liposome Assisted Drug Delivery Market Perspective (2020-2031)
2.2 Global Liposome Assisted Drug Delivery Growth Trends by Region
2.2.1 Global Liposome Assisted Drug Delivery Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Liposome Assisted Drug Delivery Historic Market Size by Region (2020-2025)
2.2.3 Liposome Assisted Drug Delivery Forecasted Market Size by Region (2026-2031)
2.3 Liposome Assisted Drug Delivery Market Dynamics
2.3.1 Liposome Assisted Drug Delivery Industry Trends
2.3.2 Liposome Assisted Drug Delivery Market Drivers
2.3.3 Liposome Assisted Drug Delivery Market Challenges
2.3.4 Liposome Assisted Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liposome Assisted Drug Delivery Players by Revenue
3.1.1 Global Top Liposome Assisted Drug Delivery Players by Revenue (2020-2025)
3.1.2 Global Liposome Assisted Drug Delivery Revenue Market Share by Players (2020-2025)
3.2 Global Liposome Assisted Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Liposome Assisted Drug Delivery Revenue
3.4 Global Liposome Assisted Drug Delivery Market Concentration Ratio
3.4.1 Global Liposome Assisted Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liposome Assisted Drug Delivery Revenue in 2024
3.5 Global Key Players of Liposome Assisted Drug Delivery Head office and Area Served
3.6 Global Key Players of Liposome Assisted Drug Delivery, Product and Application
3.7 Global Key Players of Liposome Assisted Drug Delivery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Liposome Assisted Drug Delivery Breakdown Data by Type
4.1 Global Liposome Assisted Drug Delivery Historic Market Size by Type (2020-2025)
4.2 Global Liposome Assisted Drug Delivery Forecasted Market Size by Type (2026-2031)
5 Liposome Assisted Drug Delivery Breakdown Data by Application
5.1 Global Liposome Assisted Drug Delivery Historic Market Size by Application (2020-2025)
5.2 Global Liposome Assisted Drug Delivery Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Liposome Assisted Drug Delivery Market Size (2020-2031)
6.2 North America Liposome Assisted Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Liposome Assisted Drug Delivery Market Size by Country (2020-2025)
6.4 North America Liposome Assisted Drug Delivery Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liposome Assisted Drug Delivery Market Size (2020-2031)
7.2 Europe Liposome Assisted Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Liposome Assisted Drug Delivery Market Size by Country (2020-2025)
7.4 Europe Liposome Assisted Drug Delivery Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liposome Assisted Drug Delivery Market Size (2020-2031)
8.2 Asia-Pacific Liposome Assisted Drug Delivery Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Liposome Assisted Drug Delivery Market Size by Region (2020-2025)
8.4 Asia-Pacific Liposome Assisted Drug Delivery Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liposome Assisted Drug Delivery Market Size (2020-2031)
9.2 Latin America Liposome Assisted Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Liposome Assisted Drug Delivery Market Size by Country (2020-2025)
9.4 Latin America Liposome Assisted Drug Delivery Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liposome Assisted Drug Delivery Market Size (2020-2031)
10.2 Middle East & Africa Liposome Assisted Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Liposome Assisted Drug Delivery Market Size by Country (2020-2025)
10.4 Middle East & Africa Liposome Assisted Drug Delivery Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Details
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Liposome Assisted Drug Delivery Introduction
11.1.4 Gilead Sciences Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.1.5 Gilead Sciences Recent Development
11.2 Pacira
11.2.1 Pacira Company Details
11.2.2 Pacira Business Overview
11.2.3 Pacira Liposome Assisted Drug Delivery Introduction
11.2.4 Pacira Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.2.5 Pacira Recent Development
11.3 Sun Pharmaceutical
11.3.1 Sun Pharmaceutical Company Details
11.3.2 Sun Pharmaceutical Business Overview
11.3.3 Sun Pharmaceutical Liposome Assisted Drug Delivery Introduction
11.3.4 Sun Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.3.5 Sun Pharmaceutical Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Liposome Assisted Drug Delivery Introduction
11.4.4 Johnson & Johnson Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.4.5 Johnson & Johnson Recent Development
11.5 Luye Pharma
11.5.1 Luye Pharma Company Details
11.5.2 Luye Pharma Business Overview
11.5.3 Luye Pharma Liposome Assisted Drug Delivery Introduction
11.5.4 Luye Pharma Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.5.5 Luye Pharma Recent Development
11.6 Sigma-Tau Group
11.6.1 Sigma-Tau Group Company Details
11.6.2 Sigma-Tau Group Business Overview
11.6.3 Sigma-Tau Group Liposome Assisted Drug Delivery Introduction
11.6.4 Sigma-Tau Group Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.6.5 Sigma-Tau Group Recent Development
11.7 Ipsen (Onivyde)
11.7.1 Ipsen (Onivyde) Company Details
11.7.2 Ipsen (Onivyde) Business Overview
11.7.3 Ipsen (Onivyde) Liposome Assisted Drug Delivery Introduction
11.7.4 Ipsen (Onivyde) Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.7.5 Ipsen (Onivyde) Recent Development
11.8 CSPC
11.8.1 CSPC Company Details
11.8.2 CSPC Business Overview
11.8.3 CSPC Liposome Assisted Drug Delivery Introduction
11.8.4 CSPC Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.8.5 CSPC Recent Development
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Details
11.9.2 Teva Pharmaceutical Business Overview
11.9.3 Teva Pharmaceutical Liposome Assisted Drug Delivery Introduction
11.9.4 Teva Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.9.5 Teva Pharmaceutical Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Liposome Assisted Drug Delivery Introduction
11.10.4 Novartis Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.10.5 Novartis Recent Development
11.11 Fudan-Zhangjiang
11.11.1 Fudan-Zhangjiang Company Details
11.11.2 Fudan-Zhangjiang Business Overview
11.11.3 Fudan-Zhangjiang Liposome Assisted Drug Delivery Introduction
11.11.4 Fudan-Zhangjiang Revenue in Liposome Assisted Drug Delivery Business (2020-2025)
11.11.5 Fudan-Zhangjiang Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Liposome Assisted Drug Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Liposomal Doxorubicin
Table 3. Key Players of Liposomal Amphoteracin B
Table 4. Key Players of Liposomal Paclitaxel
Table 5. Key Players of Others
Table 6. Global Liposome Assisted Drug Delivery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Liposome Assisted Drug Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Liposome Assisted Drug Delivery Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Liposome Assisted Drug Delivery Market Share by Region (2020-2025)
Table 10. Global Liposome Assisted Drug Delivery Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Liposome Assisted Drug Delivery Market Share by Region (2026-2031)
Table 12. Liposome Assisted Drug Delivery Market Trends
Table 13. Liposome Assisted Drug Delivery Market Drivers
Table 14. Liposome Assisted Drug Delivery Market Challenges
Table 15. Liposome Assisted Drug Delivery Market Restraints
Table 16. Global Liposome Assisted Drug Delivery Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Liposome Assisted Drug Delivery Market Share by Players (2020-2025)
Table 18. Global Top Liposome Assisted Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposome Assisted Drug Delivery as of 2024)
Table 19. Ranking of Global Top Liposome Assisted Drug Delivery Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Liposome Assisted Drug Delivery Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Liposome Assisted Drug Delivery, Headquarters and Area Served
Table 22. Global Key Players of Liposome Assisted Drug Delivery, Product and Application
Table 23. Global Key Players of Liposome Assisted Drug Delivery, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Liposome Assisted Drug Delivery Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Liposome Assisted Drug Delivery Revenue Market Share by Type (2020-2025)
Table 27. Global Liposome Assisted Drug Delivery Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Liposome Assisted Drug Delivery Revenue Market Share by Type (2026-2031)
Table 29. Global Liposome Assisted Drug Delivery Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Liposome Assisted Drug Delivery Revenue Market Share by Application (2020-2025)
Table 31. Global Liposome Assisted Drug Delivery Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Liposome Assisted Drug Delivery Revenue Market Share by Application (2026-2031)
Table 33. North America Liposome Assisted Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Liposome Assisted Drug Delivery Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Liposome Assisted Drug Delivery Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Liposome Assisted Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Liposome Assisted Drug Delivery Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Liposome Assisted Drug Delivery Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Liposome Assisted Drug Delivery Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Liposome Assisted Drug Delivery Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Liposome Assisted Drug Delivery Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Liposome Assisted Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Liposome Assisted Drug Delivery Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Liposome Assisted Drug Delivery Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Liposome Assisted Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Liposome Assisted Drug Delivery Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Liposome Assisted Drug Delivery Market Size by Country (2026-2031) & (US$ Million)
Table 48. Gilead Sciences Company Details
Table 49. Gilead Sciences Business Overview
Table 50. Gilead Sciences Liposome Assisted Drug Delivery Product
Table 51. Gilead Sciences Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 52. Gilead Sciences Recent Development
Table 53. Pacira Company Details
Table 54. Pacira Business Overview
Table 55. Pacira Liposome Assisted Drug Delivery Product
Table 56. Pacira Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 57. Pacira Recent Development
Table 58. Sun Pharmaceutical Company Details
Table 59. Sun Pharmaceutical Business Overview
Table 60. Sun Pharmaceutical Liposome Assisted Drug Delivery Product
Table 61. Sun Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 62. Sun Pharmaceutical Recent Development
Table 63. Johnson & Johnson Company Details
Table 64. Johnson & Johnson Business Overview
Table 65. Johnson & Johnson Liposome Assisted Drug Delivery Product
Table 66. Johnson & Johnson Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 67. Johnson & Johnson Recent Development
Table 68. Luye Pharma Company Details
Table 69. Luye Pharma Business Overview
Table 70. Luye Pharma Liposome Assisted Drug Delivery Product
Table 71. Luye Pharma Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 72. Luye Pharma Recent Development
Table 73. Sigma-Tau Group Company Details
Table 74. Sigma-Tau Group Business Overview
Table 75. Sigma-Tau Group Liposome Assisted Drug Delivery Product
Table 76. Sigma-Tau Group Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 77. Sigma-Tau Group Recent Development
Table 78. Ipsen (Onivyde) Company Details
Table 79. Ipsen (Onivyde) Business Overview
Table 80. Ipsen (Onivyde) Liposome Assisted Drug Delivery Product
Table 81. Ipsen (Onivyde) Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 82. Ipsen (Onivyde) Recent Development
Table 83. CSPC Company Details
Table 84. CSPC Business Overview
Table 85. CSPC Liposome Assisted Drug Delivery Product
Table 86. CSPC Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 87. CSPC Recent Development
Table 88. Teva Pharmaceutical Company Details
Table 89. Teva Pharmaceutical Business Overview
Table 90. Teva Pharmaceutical Liposome Assisted Drug Delivery Product
Table 91. Teva Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 92. Teva Pharmaceutical Recent Development
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Liposome Assisted Drug Delivery Product
Table 96. Novartis Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 97. Novartis Recent Development
Table 98. Fudan-Zhangjiang Company Details
Table 99. Fudan-Zhangjiang Business Overview
Table 100. Fudan-Zhangjiang Liposome Assisted Drug Delivery Product
Table 101. Fudan-Zhangjiang Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 102. Fudan-Zhangjiang Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Liposome Assisted Drug Delivery Picture
Figure 2. Global Liposome Assisted Drug Delivery Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Liposome Assisted Drug Delivery Market Share by Type: 2024 VS 2031
Figure 4. Liposomal Doxorubicin Features
Figure 5. Liposomal Amphoteracin B Features
Figure 6. Liposomal Paclitaxel Features
Figure 7. Others Features
Figure 8. Global Liposome Assisted Drug Delivery Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Liposome Assisted Drug Delivery Market Share by Application: 2024 VS 2031
Figure 10. Fungal Infection Therapy Case Studies
Figure 11. Cancer & Tumor Therapy Case Studies
Figure 12. Others Case Studies
Figure 13. Liposome Assisted Drug Delivery Report Years Considered
Figure 14. Global Liposome Assisted Drug Delivery Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Liposome Assisted Drug Delivery Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Liposome Assisted Drug Delivery Market Share by Region: 2024 VS 2031
Figure 17. Global Liposome Assisted Drug Delivery Market Share by Players in 2024
Figure 18. Global Top Liposome Assisted Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposome Assisted Drug Delivery as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Liposome Assisted Drug Delivery Revenue in 2024
Figure 20. North America Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Liposome Assisted Drug Delivery Market Share by Country (2020-2031)
Figure 22. United States Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Liposome Assisted Drug Delivery Market Share by Country (2020-2031)
Figure 26. Germany Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Liposome Assisted Drug Delivery Market Share by Region (2020-2031)
Figure 34. China Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Liposome Assisted Drug Delivery Market Share by Country (2020-2031)
Figure 42. Mexico Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Liposome Assisted Drug Delivery Market Share by Country (2020-2031)
Figure 46. Turkey Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Gilead Sciences Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 50. Pacira Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 51. Sun Pharmaceutical Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 52. Johnson & Johnson Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 53. Luye Pharma Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 54. Sigma-Tau Group Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 55. Ipsen (Onivyde) Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 56. CSPC Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 57. Teva Pharmaceutical Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 58. Novartis Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 59. Fudan-Zhangjiang Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Liposome Assisted Drug Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Liposomal Doxorubicin
Table 3. Key Players of Liposomal Amphoteracin B
Table 4. Key Players of Liposomal Paclitaxel
Table 5. Key Players of Others
Table 6. Global Liposome Assisted Drug Delivery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Liposome Assisted Drug Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Liposome Assisted Drug Delivery Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Liposome Assisted Drug Delivery Market Share by Region (2020-2025)
Table 10. Global Liposome Assisted Drug Delivery Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Liposome Assisted Drug Delivery Market Share by Region (2026-2031)
Table 12. Liposome Assisted Drug Delivery Market Trends
Table 13. Liposome Assisted Drug Delivery Market Drivers
Table 14. Liposome Assisted Drug Delivery Market Challenges
Table 15. Liposome Assisted Drug Delivery Market Restraints
Table 16. Global Liposome Assisted Drug Delivery Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Liposome Assisted Drug Delivery Market Share by Players (2020-2025)
Table 18. Global Top Liposome Assisted Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposome Assisted Drug Delivery as of 2024)
Table 19. Ranking of Global Top Liposome Assisted Drug Delivery Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Liposome Assisted Drug Delivery Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Liposome Assisted Drug Delivery, Headquarters and Area Served
Table 22. Global Key Players of Liposome Assisted Drug Delivery, Product and Application
Table 23. Global Key Players of Liposome Assisted Drug Delivery, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Liposome Assisted Drug Delivery Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Liposome Assisted Drug Delivery Revenue Market Share by Type (2020-2025)
Table 27. Global Liposome Assisted Drug Delivery Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Liposome Assisted Drug Delivery Revenue Market Share by Type (2026-2031)
Table 29. Global Liposome Assisted Drug Delivery Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Liposome Assisted Drug Delivery Revenue Market Share by Application (2020-2025)
Table 31. Global Liposome Assisted Drug Delivery Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Liposome Assisted Drug Delivery Revenue Market Share by Application (2026-2031)
Table 33. North America Liposome Assisted Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Liposome Assisted Drug Delivery Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Liposome Assisted Drug Delivery Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Liposome Assisted Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Liposome Assisted Drug Delivery Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Liposome Assisted Drug Delivery Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Liposome Assisted Drug Delivery Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Liposome Assisted Drug Delivery Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Liposome Assisted Drug Delivery Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Liposome Assisted Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Liposome Assisted Drug Delivery Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Liposome Assisted Drug Delivery Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Liposome Assisted Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Liposome Assisted Drug Delivery Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Liposome Assisted Drug Delivery Market Size by Country (2026-2031) & (US$ Million)
Table 48. Gilead Sciences Company Details
Table 49. Gilead Sciences Business Overview
Table 50. Gilead Sciences Liposome Assisted Drug Delivery Product
Table 51. Gilead Sciences Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 52. Gilead Sciences Recent Development
Table 53. Pacira Company Details
Table 54. Pacira Business Overview
Table 55. Pacira Liposome Assisted Drug Delivery Product
Table 56. Pacira Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 57. Pacira Recent Development
Table 58. Sun Pharmaceutical Company Details
Table 59. Sun Pharmaceutical Business Overview
Table 60. Sun Pharmaceutical Liposome Assisted Drug Delivery Product
Table 61. Sun Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 62. Sun Pharmaceutical Recent Development
Table 63. Johnson & Johnson Company Details
Table 64. Johnson & Johnson Business Overview
Table 65. Johnson & Johnson Liposome Assisted Drug Delivery Product
Table 66. Johnson & Johnson Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 67. Johnson & Johnson Recent Development
Table 68. Luye Pharma Company Details
Table 69. Luye Pharma Business Overview
Table 70. Luye Pharma Liposome Assisted Drug Delivery Product
Table 71. Luye Pharma Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 72. Luye Pharma Recent Development
Table 73. Sigma-Tau Group Company Details
Table 74. Sigma-Tau Group Business Overview
Table 75. Sigma-Tau Group Liposome Assisted Drug Delivery Product
Table 76. Sigma-Tau Group Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 77. Sigma-Tau Group Recent Development
Table 78. Ipsen (Onivyde) Company Details
Table 79. Ipsen (Onivyde) Business Overview
Table 80. Ipsen (Onivyde) Liposome Assisted Drug Delivery Product
Table 81. Ipsen (Onivyde) Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 82. Ipsen (Onivyde) Recent Development
Table 83. CSPC Company Details
Table 84. CSPC Business Overview
Table 85. CSPC Liposome Assisted Drug Delivery Product
Table 86. CSPC Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 87. CSPC Recent Development
Table 88. Teva Pharmaceutical Company Details
Table 89. Teva Pharmaceutical Business Overview
Table 90. Teva Pharmaceutical Liposome Assisted Drug Delivery Product
Table 91. Teva Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 92. Teva Pharmaceutical Recent Development
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Liposome Assisted Drug Delivery Product
Table 96. Novartis Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 97. Novartis Recent Development
Table 98. Fudan-Zhangjiang Company Details
Table 99. Fudan-Zhangjiang Business Overview
Table 100. Fudan-Zhangjiang Liposome Assisted Drug Delivery Product
Table 101. Fudan-Zhangjiang Revenue in Liposome Assisted Drug Delivery Business (2020-2025) & (US$ Million)
Table 102. Fudan-Zhangjiang Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Liposome Assisted Drug Delivery Picture
Figure 2. Global Liposome Assisted Drug Delivery Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Liposome Assisted Drug Delivery Market Share by Type: 2024 VS 2031
Figure 4. Liposomal Doxorubicin Features
Figure 5. Liposomal Amphoteracin B Features
Figure 6. Liposomal Paclitaxel Features
Figure 7. Others Features
Figure 8. Global Liposome Assisted Drug Delivery Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Liposome Assisted Drug Delivery Market Share by Application: 2024 VS 2031
Figure 10. Fungal Infection Therapy Case Studies
Figure 11. Cancer & Tumor Therapy Case Studies
Figure 12. Others Case Studies
Figure 13. Liposome Assisted Drug Delivery Report Years Considered
Figure 14. Global Liposome Assisted Drug Delivery Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Liposome Assisted Drug Delivery Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Liposome Assisted Drug Delivery Market Share by Region: 2024 VS 2031
Figure 17. Global Liposome Assisted Drug Delivery Market Share by Players in 2024
Figure 18. Global Top Liposome Assisted Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposome Assisted Drug Delivery as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Liposome Assisted Drug Delivery Revenue in 2024
Figure 20. North America Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Liposome Assisted Drug Delivery Market Share by Country (2020-2031)
Figure 22. United States Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Liposome Assisted Drug Delivery Market Share by Country (2020-2031)
Figure 26. Germany Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Liposome Assisted Drug Delivery Market Share by Region (2020-2031)
Figure 34. China Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Liposome Assisted Drug Delivery Market Share by Country (2020-2031)
Figure 42. Mexico Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Liposome Assisted Drug Delivery Market Share by Country (2020-2031)
Figure 46. Turkey Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Liposome Assisted Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Gilead Sciences Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 50. Pacira Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 51. Sun Pharmaceutical Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 52. Johnson & Johnson Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 53. Luye Pharma Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 54. Sigma-Tau Group Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 55. Ipsen (Onivyde) Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 56. CSPC Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 57. Teva Pharmaceutical Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 58. Novartis Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 59. Fudan-Zhangjiang Revenue Growth Rate in Liposome Assisted Drug Delivery Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232